Niche CRO Advantage Concentrics Research specializes in late-stage (Phase II-IV) and consumer healthcare research with unique testing capabilities, including early iterative and single-site testing, offering a compelling value proposition for sponsors seeking efficient, scalable late-stage study support.

IQVIA Affiliation As an IQVIA business, Concentrics Research can leverage a strong brand association and potential cross-sell opportunities within a large ecosystem of life sciences services to pursue broader contracts with pharma and biotech clients.

Multi‑Divisional Capabilities With divisions in clinical research and regulated healthcare market research, there is potential to upsell integrated services to clients needing both clinical endpoints and market access or regulatory strategy support.

Scaled Networking Despite a smaller team size (11-50 employees), the company sits in a market with giants; there are opportunities to target mid-to-large CROs or sponsors looking for nimble partners with specialized testing sites and faster iteration cycles.

Financial Scaling Reported revenue in the mid‑tens of millions positions Concentrics as a credible partner for mid-market pharmaceutical and consumer health brands seeking proven ROI; cross-sell to adjacent services and explore longer-term framework agreements to stabilize revenue.